Mitochondrial oxidative damage in aging and Alzheimer's disease: implications for mitochondrially targeted antioxidant therapeutics
about
The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodiesInnovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis PathwayShift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventionsTargeting the prodromal stage of Alzheimer's disease: bioenergetic and mitochondrial opportunitiesDynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseasesThe abolishment of anesthesia-induced cognitive impairment by timely protection of mitochondria in the developing rat brain: the importance of free oxygen radicals and mitochondrial integrityAnesthesia-induced developmental neurodegeneration: the role of neuronal organelles.Pathogenesis of Alzheimer's diseaseAmyloid-beta and mitochondria in aging and Alzheimer's disease: implications for synaptic damage and cognitive declineA haplotype variation affecting the mitochondrial transportation of hMYH protein could be a risk factor for colorectal cancer in Chinese.Dietary Sugars and Endogenous Formation of Advanced Glycation Endproducts: Emerging Mechanisms of Disease.Estrogen: a master regulator of bioenergetic systems in the brain and bodyMitochondrial dynamics in Alzheimer's disease: opportunities for future treatment strategies.Oxidative stress, mitochondrial damage and neurodegenerative diseasesTargeting mitochondrial bioenergetics for Alzheimer's prevention and treatment.An overview of biomarkers in Alzheimer's disease.Mitochondrial Dysfunction and Oxidative Stress in Asthma: Implications for Mitochondria-Targeted Antioxidant TherapeuticsAssessment of newly synthesized mitochondrial DNA using BrdU labeling in primary neurons from Alzheimer's disease mice: Implications for impaired mitochondrial biogenesis and synaptic damage.Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies.Aging and amyloid beta-induced oxidative DNA damage and mitochondrial dysfunction in Alzheimer's disease: implications for early intervention and therapeutics.Mitochondrial medicine for aging and neurodegenerative diseasesAbnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: implications to mitochondria-targeted antioxidant therapeuticsRole and treatment of mitochondrial DNA-related mitochondrial dysfunction in sporadic neurodegenerative diseases.Excitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis.Mitochondria-Targeted Antioxidant SS31 Prevents Amyloid Beta-Induced Mitochondrial Abnormalities and Synaptic Degeneration in Alzheimer's DiseaseProgesterone and estrogen regulate oxidative metabolism in brain mitochondria.Decursin Isolated from Angelica gigas Nakai Rescues PC12 Cells from Amyloid β-Protein-Induced Neurotoxicity through Nrf2-Mediated Upregulation of Heme Oxygenase-1: Potential Roles of MAPKOxidative impairment of hippocampal long-term potentiation involves activation of protein phosphatase 2A and is prevented by ketone bodies.Mitochondria-targeted molecules MitoQ and SS31 reduce mutant huntingtin-induced mitochondrial toxicity and synaptic damage in Huntington's disease.MitoQ, a mitochondria-targeted antioxidant, delays disease progression and alleviates pathogenesis in an experimental autoimmune encephalomyelitis mouse model of multiple sclerosis.Mitochondria: a therapeutic target in neurodegenerationEstrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease.Bioenergetic medicine.Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesisOxidative stress and Alzheimer's disease: dietary polyphenols as potential therapeutic agents.Mitochondrial biology in Alzheimer's disease pathogenesis.Antioxidant approaches for the treatment of Alzheimer's disease.A matter of life, death and diseases: mitochondria from a proteomic perspective.Mitochondria-Targeted Antioxidants for the Treatment of Cardiovascular Disorders.Mitochondrial dysfunction and oxidative stress in metabolic disorders - A step towards mitochondria based therapeutic strategies.
P2860
Q24646616-3739D373-3D6A-4DD8-91BD-5D616879E4AAQ26771260-8781C7A1-4B9D-411B-A499-058225AE130EQ26830740-0DAD1A83-0505-44A6-9169-B24D3FC666CCQ27338799-7F01FDD6-862B-4F13-BA7A-3F68865304FDQ28300234-5482506E-1CDB-4D42-9E9A-AE92E4A7958EQ30422273-768F9574-35D8-4B88-AC5A-815C76719630Q30424486-4F0C5192-78C0-4A7A-9753-87AF476E2BE5Q30439489-3258B88C-6D6B-439A-BB06-A0DF2254A548Q30476347-C1EFE6E9-92E4-4693-BA08-D2225D48CA81Q33371362-2E31E339-3CE0-43D9-95D9-0AA6074756C8Q33616876-B7BD184A-C9AB-4E94-92FC-FF44FA680105Q33623924-31349406-F9F8-40EA-80A7-A9C16E3FBC57Q34073939-E539FA48-4B34-4E6E-91C8-497A54FED003Q34094532-B58203AE-30DB-4113-94E6-40C630110A2AQ34407220-75028C1C-0253-4785-B41A-0F719A77B609Q34574944-47062A27-CECD-4AFF-9001-F5583A301D4EQ34731547-032FC4BA-50E6-45B6-BBE8-9CFA21032160Q35126945-8FD3354D-050F-4F09-8928-E3BF3F87D563Q35140660-8F490F88-7AAE-4827-907D-A99030C532F3Q35256535-FD37E06F-64D6-444F-9D4B-128F1C7BE27FQ35606693-FFECD4DA-7DA6-4FEE-8C42-B2865B6A8734Q35737647-70A4ABC2-36D9-46B5-9546-2A0EEE423FD1Q35958359-46762687-29A6-445C-A2E4-AF4F0B019A44Q36283207-C5AE203C-96A3-4530-955E-E74C2540DAF0Q36441971-150D1D08-2049-4F87-8C4F-4A38DD38031EQ36692052-B7430B5C-B84D-4671-9B7F-E7D0BE27F6ACQ36879814-85770D97-116B-4DB6-AB30-F61262B9A66CQ36954084-336C93A4-CC89-4C2F-B59A-365A1C368EC2Q37178581-73AF3708-CA7B-4D1A-9E62-DB8126E7626FQ37315208-93701C31-0AB5-4441-9979-A1014F09E729Q37466059-8BD5074C-A7CC-4483-A44B-8F5E8AD62643Q37675866-6A30EAD4-0DE5-4F89-890B-FF19F35DA343Q37686246-91BE8335-7334-4C30-90A4-32700FF8C78CQ37690524-2458A9D4-DEA4-4BA1-B86F-697E1F2BE466Q37737299-6143A0E5-3724-40CB-BC5D-50D375665A79Q37759167-B78E4CE4-A845-4E06-8749-856B8402DF1FQ37768449-6F6EEC13-8B76-4E53-B2F8-7DB280C38E73Q38081957-66A32D6C-7299-4C7F-936A-8AA963DB076CQ38678059-2E41A047-51C6-4A57-815B-BA8BD7804644Q39005762-E5A83DD3-DC7C-4A2A-8700-A02E5724200B
P2860
Mitochondrial oxidative damage in aging and Alzheimer's disease: implications for mitochondrially targeted antioxidant therapeutics
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Mitochondrial oxidative damage ...... geted antioxidant therapeutics
@ast
Mitochondrial oxidative damage ...... geted antioxidant therapeutics
@en
type
label
Mitochondrial oxidative damage ...... geted antioxidant therapeutics
@ast
Mitochondrial oxidative damage ...... geted antioxidant therapeutics
@en
prefLabel
Mitochondrial oxidative damage ...... geted antioxidant therapeutics
@ast
Mitochondrial oxidative damage ...... geted antioxidant therapeutics
@en
P2860
P356
P1476
Mitochondrial oxidative damage ...... geted antioxidant therapeutics
@en
P2093
P Hemachandra Reddy
P2860
P356
10.1155/JBB/2006/31372
P577
2006-01-01T00:00:00Z